News & Events

Recent Press Releases

• 
  NCI study revises molecular classification for most common type of lymphoma

  April 11, 2018

  In a study in The New England Journal of Medicine, NCI researchers identified genetic subtypes of diffuse large B-cell lymphoma (DLBCL), the most common type of lymphoma, that could help explain why some patients with the disease respond to treatment and others don’t.

• 
  NIH completes in-depth genomic analysis of 33 cancer types

  April 5, 2018

  The Cancer Genome Atlas (TCGA), supported by NIH’s NHGRI and NCI, concludes with an in-depth genomic analysis of 33 cancer types called the PanCancer Atlas. Findings are being published as a collection of 27 papers across multiple Cell journals.

• 
  NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

  March 28, 2018

  Interim results from a clinical trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF) show that the drug sorafenib tosylate (Nexavar) extended progression-free survival compared with a placebo.

• 
  Szent-Györgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller

  February 15, 2018

  Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute will receive the 2018 Szent-Gyorgyi Prize for Progress in Cancer Research for the development of HPV vaccines.

• 
  Norman Sharpless sworn in as director of the National Cancer Institute

  October 18, 2017

  Norman E. “Ned” Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center.

• 
  NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers

  September 26, 2017

  TMIST, the first randomized trial comparing two types of digital mammography for breast cancer screening, is enrolling participants. Developed by ECOG-ACRIN and NCI, the trial is comparing 2-D and 3-D mammography for finding breast cancers.

• 
  NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

  September 6, 2017

  Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines.

• 
  NCI study identifies essential genes for cancer immunotherapy

  August 7, 2017

  A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients.

• 
  NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome

  August 3, 2017

  A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers.

• 
  NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

  July 24, 2017

  The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations.

•  
  All NCI news